Abstract
Granulomatous diseases are the heterogeneous group of the conditions of different etiologies with a variety of clinic syndromes and morphological features and nonuniform sensitivity to therapy, and the existence of granulomas as general dominate histological expression. Granuloma is indicative of chronic inflammation involving cells of the macrophage system and other inflammatory cells. After the antigen exposure, the activation of T-lymphocytes, macrophages, and epithelioid histiocytes leads to granuloma formation. Granuloma also contains the extracellular matrix produced by fibroblasts, which provide the boundary and isolation of antigen. Their etiology may classify granulomatous diseases as infectious and noninfectious. However, recent studies demonstrate that pathogenic microorganisms may cause the granuloma formation in diseases previously considered as noninfectious. In some cases, differentiation between infectious and noninfectious processes may be problematic. This chapter aims to highlight the multiformity of granulomatous diseases, characterize the pathologic features of different infectious and noninfectious granulomatosis, and delineate the diagnostic approach.
Keywords
- lung pathology
- granulomatous diseases
- sarcoidosis
- infection
- vasculitis
1. Introduction
Granulomatous diseases are a heterogeneous group of the conditions of various etiologies with a variety of clinic syndromes and morphological features, nonuniform sensitivity to therapy, and the existence of granulomas. Granuloma is indicative of chronic inflammation involving cells of the macrophage system and other inflammatory cells. After antigen exposure, the activation of T-lymphocytes, macrophages, and epithelioid histiocytes lead to granuloma formation. Granulomas also contain the extracellular matrix produced by fibroblasts, which provide the boundary and isolation of antigens. Their etiology may classify granulomatous diseases as infectious and noninfectious. However, recent studies demonstrate that pathogenic microorganisms may cause the granuloma formation in diseases previously considered as noninfectious. In some cases, differentiation between infectious and noninfectious processes may be problematic. This chapter aims to highlight the multiple forms of granulomatous diseases, characterize the pathologic features of different infectious and noninfectious granulomatosis, and delineate the diagnostic approach.
The term granuloma comes from the Latin word “
Granulomatous diseases are the heterogeneous group of the diseases of different etiology with a variety of clinic syndromes and morphological features, nonuniform sensitivity to therapy [3]. This chapter aims to highlight the variety of granulomatous lung diseases, to characterize the key morphological features of various diseases of infectious and noninfectious nature, as well as to delineate the diagnostic approach. First, the granulomatous diseases, with arising granulomas which do not lead to necrosis development, with some exceptions are mentioned.
2. Sarcoidosis
Lung lesions in sarcoidosis are described in 90% of cases. The morphological feature of sarcoidosis is epithelioid cell granuloma, which is a compact formation of mononuclear phagocytes (macrophages and epithelioid cells). Each sarcoid granuloma has certain stages of development. These stages are as follows:
Early or macrophage granuloma, sometimes with a few histiocytes, lymphocytes, or neutrophils (Figure 1);
Granuloma with an epithelioid cell cluster in the center and macrophages at the periphery;
Lymphocytic epithelioid granuloma;
The appearance of giant multinucleated cells (at first foreign-body giant cells, followed by Langhans cells);
Early cell necrosis in the center of the granuloma due to nuclear pycnosis, the formation of apoptotic bodies, and epithelial cell necrosis;
Central fibrinoid, granular, coagulative ischemic necrosis, as a rule, in small foci;
Granuloma with fibrosis (or hyalinosis); silver stain is used to detect reticulin fibers;
Hyalinized granuloma.
The process of granuloma organization begins at the periphery; that is why they have well-defined, “stamped” appearance (Figure 2).
Moreover, in sarcoidosis, granulomas of different “age” may be frequently found in the same samples; granulomas often form conglomerates (Figure 3) [4].
A significant number of lymphocytes in lung tissue in patients with sarcoidosis are predominantly represented by T-cells. It is useful to evaluate the bronchioloalveolar lavage (BAL) while carrying out the differential diagnosis: In sarcoidosis T-helpers predominate. Giant cells in granulomas may contain cytoplasmic inclusions, such as asteroid bodies, Schaumann bodies, or crystalloid structures. These inclusions are characteristic of sarcoidosis, but they are not pathognomonic, as they may be found in other granulomatous diseases [5]. The end stage of sarcoidosis is characterized with prominent fibrosis, sometimes with honeycombing, in which only the remnants of granulomas could be found (Figure 4).
Typical locations of granulomas in sarcoidosis are perilymphatic or subpleural zones. Granulomas in bronchi and bronchioles may be found in 15–55% cases of sarcoidosis. Furthermore, granulomas are often located in the vessel wall; the frequency of granulomatous vasculitis may reach 69% (Figure 5). In these cases, sarcoidosis should be differentiated from necrotizing sarcoid granulomatosis. The latter is attributed by some authors to the nodular form of sarcoidosis; necrosis is typical for this disease [6].
Summing up, sarcoidosis is characterized by sharply defined, “stamped” granulomas located along the lymphatic vessels with concentric fibrosis around the granulomas and hyalinosis inside and between the granulomas, also by granulomatous vasculitis, the absence of chronic interstitial inflammation outside the granulomatous lesions, and the absence of organized pneumonia foci. Apart from sarcoidosis, a so-called nonspecific sarcoid reaction occurs in the form of epithelioid cell granulomatosis. It is usually observed in regional lymph nodes, but may also be found in lung tissue in pseudotumors, malignant neoplasms, parasitic diseases, and tuberculosis. Histologically, the sarcoid reaction is characterized by its locality and a topical relationship with these pathological processes.
2.1 Hypersensitivity pneumonitis
The pathogenesis of hypersensitivity pneumonitis is based on type III (immunocomplex) and type IV immunological reactions in the lung during allergen inhalation. The etiological factor of this medical condition is usually thermophilic bacteria, fungi, and animal proteins. Other bacteria and their products, amoeba, and some chemicals are much less likely to cause the disease. In case of hypersensitivity pneumonitis, granulomas are poorly formed, and loose, composed of histiocytes, lymphocytes and, multinucleated cells; some eosinophils may also be identified (Figure 6) [7].
Unlike sarcoidosis, peribronchiolar localization of granulomas is typical for hypersensitivity pneumonitis. The triad of pathomorphological features characterizes hypersensitivity pneumonitis: Nonspecific interstitial pneumonia in the peribronchiolar zones, non-necrotizing histiocytic (giant cell) granulomas, and foci of bronchiolitis obliterans. “Needle-like” inclusions are often observed inside giant cells in the granuloma areas and the alveoli in hypersensitivity pneumonitis. In the late, fibrous stage of the disease, the histological features are similar to those in usual interstitial pneumonia, only scattered giant cells or remnants of granulomas may be found in the fibrotic areas or in the honeycomb zones in hypersensitivity pneumonitis [8].
2.2 Chronic allergic disease caused by metals
Chronic berylliosis is an allergic granulomatosis. Granulomas are similar to those in sarcoidosis and may be slightly larger. As in sarcoidosis, granulomas have perilymphatic location, and lymph nodes are usually affected. The same variant of granulomatosis may develop as a result of zirconium exposure. The diagnosis should be based on the clinical history and lymphocyte transformation test [9].
2.3 Polyangiit with granulomatosis
In our opinion, of particular difficulty is
Necrotic areas are also surrounded by a histiocytic rim; however, giant cells are usually few in number and are scattered without forming compact granulomas. A characteristic feature of polyangiitis with granulomatosis is the necrotizing vasculitis with fibrinoid necrosis of the media (Figure 8);
Such vessels are observed in the inflammation; the damage to the vessel wall is often eccentric; also, the branches of the pulmonary arteries and veins are affected in this disease. The capillaritis, accompanied by intra-alveolar hemorrhages, may also be observed. Necrotizing vasculitis may often be found in the inflammation and necrosis, but this is also in the infectious granulomatosis; therefore, to confirm the diagnosis of polyangiitis with granulomatosis, it is necessary to carefully evaluate the vessels outside necrosis, and additional stains are recommended to identify elastic tissue (Verhoeff-van Gieson stain and others). In contrast to infectious granulomatosis, lymph node involvement is not typical for polyangiitis with granulomatosis [11].
2.4 Allergic angiitis with granulomatosis
Necrotizing granulomatosis is also seen in (previously, Churg-Strauss syndrome), in combination with necrotizing vasculitis and eosinophilic pneumonia. Granulomas in allergic angiitis with granulomatosis are well formed; with central necrosis containing many eosinophils, there is also eosinophilic infiltration of the blood vessel walls and bronchioles, necrotizing vasculitis with eosinophils, and giant multinucleated cells present. However, additional clinical and laboratory data are necessary to determine the diagnosis, because the classical triad (granulomatosis, necrotizing vasculitis, and eosinophilic pneumonia) is rarely found in lungs.
2.5 Rheumatoid arthritis
Furthermore, necrotizing pulmonary granulomas may form in rheumatoid arthritis; however, the diagnosis in this case should be made with caution. First of all, one should take into account clinical data, since nodular forms of rheumatoid arthritis develop only in the active phase in seropositive patients with severe articular syndrome. As a rule, necrosis is eosinophilic, cell debris is usually located between the necrosis and the surrounding rim of histiocytes; it may be combined with vasculitis, but necrotizing vasculitis is not characteristic for this disease (Figure 9) [12]. The described histological features are practically indistinguishable from infectious granulomatosis; moreover, rare clinical cases of rheumatoid arthritis and tuberculosis combination have been described, and therefore, the infection must be thoroughly excluded.
2.6 Necrotizing sarcoid granulomatosis (NSG)
Infectious granulomatosis should also be differentiated from NSG. Some characteristics of the latter are likened to those seen in polyangiitis with granulomatosis. NSG is characterized by the interstitial necrosis, which is often eosinophilic, but sometimes may contain cellular debris. However, necrosis in NSG is combined with the non-necrotizing sarcoid-type granulomas, consisting mainly of epithelioid and giant multinucleated cells with just a small number of lymphocytes. These granulomas tend to merge and are often located near blood vessels or in its walls, but not causing vasculitis (Figure 10) [6]. The following symptom triad is obligatory for the NSG diagnosis: sarcoid-type granulomas, granulomatous vasculitis, and necrotizing inflammation.
Since necrosis in infectious granulomatosis may be of a coagulation type, pulmonary infarction should also be a part of the differential diagnosis. In the stage of organization, infarction may be surrounded by fibroblasts and inflammatory cells, resembling granulomatous inflammation. As a rule, in lung resection specimens with pulmonary infarction, thrombi can be detected in the branches of the pulmonary artery that caused the development of a pulmonary infarction [13].
2.7 Granulomatous inflammation caused by infectious agents
2.7.1 Fungi
Fungi that cause deep mycoses, as a rule, do not form granulomas in the lungs. In most cases, fungi such as
2.7.1.1 Histoplasmosis
Histoplasmosis is caused by
2.7.1.2 Cryptococcosis (European blastomycosis)
These fungi can also be located inside necrotizing granulomas (cryptococcomas) resembling those with mycobacterial and other types of fungal infections (Figure 12). In immunocompromised individuals, cryptococcal cells are found inside the alveoli, in their walls, and in the interstitium, without marked inflammatory reaction; some scattered multinucleated giant cells can be found [9].
2.7.1.3 Coccidiosis
2.7.1.4 Blastomycosis
Blastomycosis is a rare disease, and this diagnosis may be suspected when granulomatosis or giant cell lesion in combination with severe acute inflammation is detected. Blastomycosis is characterized by basophilic necrosis rich in cellular debris in contrast to eosinophilic or slightly “dirty” infectious necrotizing granulomas. Blastomycosis is often a bronchiolocentric process. Large, thick-walled, yeast-like
2.7.1.5 Pneumocystosis
Most pathologists are familiar with the conventional picture of pneumonia caused by
2.8 Parasites
2.9 Tuberculosis
Tuberculosis is caused by members of the
2.10 Non-tuberculosis mycobacteriosis
Non-tuberculosis mycobacteriosis is an inflammation caused by mycobacteria not belonging to the
tuberculous granuloma—epithelioid cell tissue, variable number of Langhans cells and the necrosis intensity, few mycobacteria;
a reactive, necrotizing multibacillarity—weak inflammatory response, abundance of mycobacteria in the necrosis area;
multibacillary histiocytosis—diffuse macrophage infiltration with an intracellular abundance of mycobacteria, no necrosis;
multibacillary minimal histiocytosis—a mild inflammatory reaction with an intracellular abundance of mycobacteria;
histoid lesion—nodular clusters of spindle-shaped macrophages with an abundance of mycobacteria;
nonspecific granulation tissue;
acute purulent abscess [21].
The MAC-hypersensitivity-like disease has also been described (or “hot tub lung”); it is caused by mycobacteria of the MAC complex, and associated with the use of sauna and showers, which leads to the aerosol inhalation. The histological features of this disease are similar to the hypersensitivity pneumonitis changes [22].
2.11 Differential diagnostics of granulomatous lung diseases
A variety of diseases leading to granulomatosis determine certain difficulties in conducting the differential diagnostics even when resectional (surgical, video-assisted) biopsies are performed, which allows obtaining a sufficient amount of material for histological evaluation [23]. However, it is not always possible to establish the cause of granulomatous inflammation. According to Ulbright and Katzenstein, who analyzed 86 solitary lung granulomas detected by X-ray, the infection caused by acid-resistant mycobacteria or fungi was confirmed in 70%. In 25 cases, the infectious etiology was not proven, while two patients were diagnosed with hyalinized granuloma, one patient—with polyangiitis with granulomatosis, and in 22 cases, it was not possible to classify the process. Also, a significant similarity of histological changes in infectious granulomas and polyangiitis with granulomatosis was found; it may be possible that the latter was a reflection of the immune response disorders to an infectious agent which could no longer be found in the tissue samples. This means that polyangiitis with granulomatosis and other lung angiitis diagnoses should be made with extreme caution in cases with solitary nodes while no damage to other organs is detected. In such cases, a thorough examination of patients and follow-up should be recommended [24].
Mukhopadhyay et al. conducted a multicenter retrospective study of 500 biopsies from 10 clinics in the United States, Britain, Austria, Brazil, Japan, Turkey, and India with pulmonary granulomatosis. During the biopsy analysis, a specific diagnosis was established in 58% of the cases: most commonly sarcoidosis (27%) and mycobacterial infection (25%) were detected. Mycobacterial infection was proved in 18% outside the USA versus 8% in the USA; on the contrary, fungal infection amounted to 19% in the USA (most often histoplasmosis) versus 4% in other countries. Fungi were commonly detected by histological examination, while mycobacterial infection was confirmed in culture. In 42% of the cases, the etiological factor of granulomatosis was not established.
This study, in our opinion, is extremely interesting: First of all, it indicates the predominance of sarcoidosis and infectious granulomatous inflammation in the structure of granulomatous diseases according to histological analysis conducted in different countries and geographical regions. Fungal infection more often caused granulomatous inflammation in the United States, while mycobacterial infection was more often diagnosed in other countries, which is a reflection of the infection endemicity. It is crucial to send the specimen simultaneously to the histological and microbiological laboratory in all cases when a granulomatous disease is suspected, that will definitely improve the quality of the etiological diagnosis. According to this study, the cause of granulomatosis was not established in more than a third of clinical cases even after histological examination [22].
The frequency of infectious granulomatosis is high. When all other causes based on the clinical history, clinical syndromes, laboratory tests, and specific morphological features mentioned above are excluded, the remaining granulomatous diseases are most likely to be attributed to infectious.
An important issue in the differential diagnosis of the infectious granulomatosis diseases is the detection of an infectious agent in microscopical slides. To achieve this, it is necessary and obligatory to perform additional stains. One can detect fungal infection, first of all, by carefully evaluating hematoxylin- and eosin-stained (H&E) slides. Most fungi, such as
Ziehl-Neelsen stain is used to diagnose mycobacterial infection; however, mycobacteria are usually few in number, and their search is quite time-consuming. Alternative stains with auramine or auramine/rhodamine increase the sensitivity of the method, but these techniques require fluorescence microscopy (Figure 16a and b). To increase the detection of mycobacteria, Ulbright and Katzenstein recommend performing staining in at least two blocks [24]. Gomori silver or Warthin-Starry stains are recommended for syphilis diagnosis [9].
One of the open questions is whether there are additional opportunities, modern techniques for diagnosing infectious granulomatosis. Immunohistochemistry is available, but it has several limitations, namely cross-reactivity, as well as the antibody accessibility, especially for rare microorganisms.
The etiological factor remains unclear in 30–40% of infectious granulomatosis even in leading US university clinics despite a complete histological evaluation of lung tissue slides, as well as correlations with clinical, microbiological, and serological data. In this regard, the question of diagnostic significance of these diseases arises. Ulbright and Katzenstein propose that such cases represent infectious granulomas in which the microorganism was destroyed and/or removed by means of the developed inflammatory process [24]. A retrospective analysis of necrotizing granulomas showed that patients who did not receive further specific therapy were still alive and did not demonstrate any clinical symptoms. The same hypothesis is confirmed by Aubry who notes that even if new foci appear in these patients, poor outcomes were not detected [10]. It can be recommended to pathologists to give a descriptive histological conclusion indicating the presence/absence of necrosis, the absence of detected microorganisms: “The disease etiology is most likely to be infectious, special stains for the microorganism detection are negative.”
When a granulomatous disease is suspected and lung resection is performed, it is necessary to save some specimen tissue unfixed for possible cultural study, and use the quick freeze method at -70°С for subsequent DNA and RNA analyses, if available. In the differential diagnosis of granulomatous diseases, first of all, one should determine whether the granuloma is infectious, or there are signs of other diseases, including Wegener’s granulomatosis. If a specific diagnosis is excluded, it is crucial to perform special stains for microorganism detection, it is preferable to stain sections from at least two blocks, while making sure that necrosis foci are present in the material. If the microorganism detection is not possible at the first glance, we recommend evaluating the slides again at a higher magnification, and also using an additional block for staining. When negative result is received, but clinical data are in favor of tuberculosis or other infections, PCR is suggested. Additional cultural and serological studies, which would be able to exclude the infectious process, should be performed in case of another negative result obtained. Nevertheless, according to this algorithm results, a certain part of granulomatous diseases appears to have an uncertain etiology.
In conclusion, we would like to emphasize that the differential diagnosis of granulomatous pulmonary diseases is not so easy for pathologists. To exclude or prove the infectious disease, the pathologist should carefully examinate special stained specimens. Noninfectious granulomatous lung disease should be proved, taking into consideration both clinical and radiological data. Finally, from the pathologic point of view, there are the situations for which a specific diagnosis cannot be made. Multidisciplinary approach sometimes is recommended for decision-making.
References
- 1.
Muller H, Kruger S. Immunohistochemical analysis of cell composition and in situ cytokine expression in HIV- and non-HIV-associated tuberculosis lymphadenitis. Immunobiology. 1994; 191 :354-368. DOI: 10.1016/s0171-2985(11)80441-9 - 2.
Enelow RI, Sullivan GW, Carper HT, Mandell GL. Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferon-gamma: Comparison with other stimulating factors. American Journal of Respiratory Cell and Molecular Biology. 1992; 6 :57-62. DOI: 10.1165/ajrcmb/6.1.57 - 3.
Strukov AI, OYA K. Granulomatous Inflammation and Granulomatous Diseases. Moscow. Medizina: AMS USSR; 1989. p. 184 - 4.
Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. American Journal of Respiratory and Critical Care Medicine. 1999; 160 :736-755. DOI: 10.1164/ajrccm.160.2.ats4-99 - 5.
Gal AA, Koss MN. The pathology of sarcoidosis. Current Opinion in Pulmonary Medicine. 2002; 8 (5):445-451. DOI: 10.1097/00063198-200209000-00018 - 6.
Popper HH, Klemen H, Colby TV, Churg A. Necrotizing sarcoid granulomatosis – is it different from nodular sarcoidosis? Pneumologie. 2003; 57 (5):268-271. DOI: 10.1055/s-2003-39365 - 7.
Coleman A, Colby TV. Histologic diagnosis of extrinsic allergic alveolitis. The American Journal of Surgical Pathology. 1988; 12 (7):514-518. DOI: 10.1097/00000478-198807000-00002 - 8.
Barrios RJ. Hypersensitivity pneumonitis: Histopathology. Archives of Pathology & Laboratory Medicine. 2008; 132 (2):199-203 - 9.
Popper HH. Epithelioid cell granulomatosis of the lung: New insights and concepts. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 1999; 16 (1):32-46 - 10.
Aubry MC. Necrotizing granulomatous inflammation: What does it mean if your special stains are negative? Modern Pathology. 2012; 25 :S31-S38. DOI: 10.1038/modpathol.2011.155 - 11.
Godman G, Churg J. Wegener’s granulomatosis. A.M.A. Archives of Pathology. 1954; 58 :533-553. DOI: 10.1016/0002-9343(54)90255-7 - 12.
Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. The American Review of Respiratory Disease. 1985; 131 (5):770-777 - 13.
Yousem SA. The surgical pathology of pulmonary infarcts: Diagnostic confusion with granulomatous disease, vasculitis, and neoplasia. Modern Pathology. 2009; 22 :679-685. DOI: 10.1038/modpathol.2009.20 - 14.
Khmel’nitskij OK, Khmel’nitskaya NM. Pathomorphology of Human Mycosis. S.-Petersburg. Publishing House of S.Petersburg’s Medical Academy of Postgraduate Education; 2005. p. 432 - 15.
Mukhopadhyay S, Gal AA. Granulomatous lung disease: An approach to the differential diagnosis. Archives of Pathology & Laboratory Medicine. 2010; 134 :667-690 - 16.
Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. The American Journal of Surgical Pathology. 1990; 14 (7):615-625. DOI: 10.1097/00000478-199007000-00002 - 17.
Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia: A histopathologic study of typical and atypical features. American Journal of Clinical Pathology. 1977; 67 (1):11-19. DOI: 10.1093/ajcp/67.1.11 - 18.
Flieder DB, Moran CA. Pulmonary dirofilariasis: A clinicopathologic study of 41 lesions in 39 patients. Human Pathology. 1999; 30 (3):251-256. DOI: 10.1016/s0046-8177(99)90001-1 - 19.
Strukov AI, Solov’eva IP. Tuberculosis Morphology in Modern Condition. Moscow: Medizina; 1976 - 20.
Corpe RF, Stergus I. Is the histopathology of nonphotochromogenic mycobacterial infections distinguishable from that caused by Mycobacterium tuberculosis? The American Review of Respiratory Disease. 1963; 87 :289-291 - 21.
Solovjeva IP, Batyrov FA, Ponomarev AB, Fedorov ВТ. Pathology of Tuberculosis and Differential Diagnostics of Granulomatous Diseases. Moscow: Atlas for the Post Graduation Education of Specialists of Scientific, Medical and Educational Institutions; 2005. p. 51 - 22.
Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, et al. Causes of pulmonary granulomas: A retrospective study of 500 cases from seven countries. Journal of Clinical Pathology. 2012; 65 :51-57. DOI: 10.1136/jclinpath-2011-200336 - 23.
Myers JL, Tazelaar HD. Challenges in pulmonary fibrosis: Problematic granulomatous lung disease. Thorax. 2008; 63 :78-84. DOI: 10.1136/thx.2004.031047 - 24.
Ulbright TM, Katzenstein AL. Solitary necrotizing granulomas of the lung: Differentiating features and etiology. The American Journal of Surgical Pathology. 1980; 4 (1):13-28. DOI: 10.1097/00000478-198002000-00002